Clinical Trial Update: Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis

View source ↗

Summary

A clinical study in psoriasis patients explores cellular and molecular mechanisms in people treated with biotherapies targeting the IL-23/IL-17 axis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Snippet

Sponsor: Institut Pasteur | Conditions: Psoriasis | Status: RECRUITING